|
Post by dreamboatcruise on Mar 8, 2016 17:46:47 GMT -5
$27 is wishful thinking. $26 is more on target. I'm a little more pessimistic. $24 by the end of the year. I'm very close to agreeing with you... just one digit off... drop the 2.
|
|
|
Post by cretin11 on Mar 8, 2016 23:00:17 GMT -5
I'm a little more pessimistic. $24 by the end of the year. I'm very close to agreeing with you... just one digit off... drop the 2. Drop the 2, yeah I'll take it. Or drop the 4 instead, might even be ok to get that high by year end.
|
|
|
Post by BlueCat on Mar 9, 2016 11:56:38 GMT -5
I need at minimum 7.50-8- and that's not quite breakeven. Anything else is just, well, a waste of time.
Would I take 26, 24, 44? You betcha. But unless something really amazing and surprising happens (and it always could), don't see it happening this year. Let's say, its a really long shot.
Is there a chance I'll get out whole and they get back to my need point by end of year? Possible. If they execute really well, and maybe something sells (big foreign sale, or what).
I mean - we were getting close just less than a year ago.
|
|
|
Post by afrizzle on Mar 13, 2016 11:27:13 GMT -5
I don't see a sale of Afrezza in the future. MannKind is putting a heck of an effort into their relabel and go it alone strategy. If they were selling it off, wouldn't they negotiate an extension of the Sanofi branding?
I also don't see a short squeeze but I am very optimistic things are going to take off.
When priced right, which should be coming soon, we,re finally going to get to see what is possible
|
|
|
Post by patten1962 on Mar 13, 2016 11:55:52 GMT -5
I don't see a sale of Afrezza in the future. MannKind is putting a heck of an effort into their relabel and go it alone strategy. If they were selling it off, wouldn't they negotiate an extension of the Sanofi branding? I also don't see a short squeeze but I am very optimistic things are going to take off. When priced right, which should be coming soon, we,re finally going to get to see what is possible I agree with you about them not selling. But I do see a short squeeze coming soon. Any kind of good news will make the shorts start buying back which will drive the stock way up. This is just my opinion
|
|
|
Post by cretin11 on Mar 13, 2016 17:41:05 GMT -5
I don't see a sale of Afrezza in the future. MannKind is putting a heck of an effort into their relabel and go it alone strategy. If they were selling it off, wouldn't they negotiate an extension of the Sanofi branding? I also don't see a short squeeze but I am very optimistic things are going to take off. When priced right, which should be coming soon, we,re finally going to get to see what is possible I agree with you about them not selling. But I do see a short squeeze coming soon. Any kind of good news will make the shorts start buying back which will drive the stock way up. This is just my opinion The short squeeze thesis is not very compelling, those of us who have been around a while have learned this the hard way.
|
|
|
Post by cretin11 on Mar 13, 2016 17:42:51 GMT -5
I don't see a sale of Afrezza in the future. MannKind is putting a heck of an effort into their relabel and go it alone strategy. If they were selling it off, wouldn't they negotiate an extension of the Sanofi branding? I also don't see a short squeeze but I am very optimistic things are going to take off. When priced right, which should be coming soon, we,re finally going to get to see what is possible How do you measure the amount of effort they're putting into the relabel and go it alone strategy? I can't really tell how much true effort is happening on this front.
|
|
|
Post by peppy on Apr 3, 2016 8:34:17 GMT -5
I realize it's a long shot, however, if we had the right catalyst and there was a squeeze how will you play it? I appreciate and respect many here (sportsrancho, lakers, harryx, baba, mholdem, robsacher, liane, suebee, compound bioexec and joypotsandpans. I know I'm forgetting many of you, please forgive me! I've recently had a tumor removed from my brain (secondary) and still have a ways to go. Obviously, it's has changed the way I look at everything! I appreciate any guidance and your time). I'm averaged down to $4.35. A newbie, I got in on FDA approval and have not sold ONE of my shares. I have always had an exit strategy but wonder if a true squeeze would work smarter in my favor to see how things run by market close or stick to my guns? Thoughts? No FUD please. I've had enough of that philosophy....I've had enough of WS, but FIRMLY believe in Mr. Mann's vision and the SCIENCE behind it. GLTAL! I think of you often and notice your name online at the board. I hope you are doing well and are being entertained by life. we can see clearly resistance, 1.57 the 2012 lows we want that to be support, and the 1.89 the resistance of the 2008 lows. through 2.16 and then 2.24 the previous highs of March, price is through a menagerie of downtrend lines, that were broken as the price night mare reveled itself. screencast.com/t/ACjRanPZ screencast.com/t/NPZ3i8w1b screencast.com/t/87yZcQ5Pg
through 2.16 then 2.24 price has the potential to move and squeeze. Matt coming to the plate.
|
|
|
Post by tayl5 on Apr 3, 2016 11:13:57 GMT -5
I agree with you about them not selling. But I do see a short squeeze coming soon. Any kind of good news will make the shorts start buying back which will drive the stock way up. This is just my opinion The short squeeze thesis is not very compelling, those of us who have been around a while have learned this the hard way. cretin11, I think the short squeeze thesis is still compelling, we just haven't seen the circumstances that would trigger it. What would it take? Any developments that would provide a clear and likely path to commercial success. The shorts who are astute enough to recognize what's happening would get the party started and as the price rises and shares are harder to get, the long awaited squeeze would commence. I know I sound like Linus describing the Great Pumpkin but it could still happen, particularly if this week has some delicious treats for longs.
|
|
|
Post by stevil on Apr 3, 2016 12:24:24 GMT -5
Have we not diluted ourselves out of a short squeeze? I realize that we were just at $7 a share less than 12 months ago, but with roughly 400 million shares, is it not expecting too much to have a short squeeze? Sure, we see TSLA and AMZN and NFLX increase by billions of dollars in a day, but is it reasonable to expect MNKD to raise more than a couple billion dollars in value in a day?
I haven't been around this stock as long as some of you have. I've not seen how easily it can move upwards.
|
|
|
Post by tayl5 on Apr 3, 2016 13:50:04 GMT -5
Think of how it looks from the other side, Stevil. Have you ever held a short position when the tide changes and you can't see a reason the price won't keep rising. It's a rather uncomfortable feeling.
From my perspective, the number of shares is not important; it's the number of shares that are short and the number available to cover that matter. It would seem the former is large, the latter is small (based on recent borrowing charges) and things could get interesting. The stock price could also just melt up or melt down if there is no compelling news. We'll find out soon enough.
|
|
|
Post by stevil on Apr 3, 2016 14:26:16 GMT -5
Think of how it looks from the other side, Stevil. Have you ever held a short position when the tide changes and you can't see a reason the price won't keep rising. It's a rather uncomfortable feeling. From my perspective, the number of shares is not important; it's the number of shares that are short and the number available to cover that matter. It would seem the former is large, the latter is small (based on recent borrowing charges) and things could get interesting. The stock price could also just melt up or melt down if there is no compelling news. We'll find out soon enough. I'm not disagreeing with you necessarily. I guess I see how it's possible, but with that many shares, there would have to be a ton of buyers to cause such a squeeze. I don't think shorts would cover unless their shares got called in. They'd know that any quick influx in price would likely be the worst time to cover, as the price would probably come down just a bit from those taking profits. Especially with a stock like this that seems to have an incredible amount of traders instead of investors. I guess it's silly to discuss it... You said it best- we'll find out soon enough.
|
|
|
Post by peppy on Apr 3, 2016 14:52:55 GMT -5
Have we not diluted ourselves out of a short squeeze? I realize that we were just at $7 a share less than 12 months ago, but with roughly 400 million shares, is it not expecting too much to have a short squeeze? Sure, we see TSLA and AMZN and NFLX increase by billions of dollars in a day, but is it reasonable to expect MNKD to raise more than a couple billion dollars in value in a day? I haven't been around this stock as long as some of you have. I've not seen how easily it can move upwards. Just when we have them by the balls. screencast.com/t/L91y1xRJ
finance.yahoo.com/q?s=mnkd Market Cap: 681.87M
|
|
|
Post by LosingMyBullishness on Apr 3, 2016 18:38:46 GMT -5
Think of how it looks from the other side, Stevil. Have you ever held a short position when the tide changes and you can't see a reason the price won't keep rising. It's a rather uncomfortable feeling. From my perspective, the number of shares is not important; it's the number of shares that are short and the number available to cover that matter. It would seem the former is large, the latter is small (based on recent borrowing charges) and things could get interesting. The stock price could also just melt up or melt down if there is no compelling news. We'll find out soon enough. I'm not disagreeing with you necessarily. I guess I see how it's possible, but with that many shares, there would have to be a ton of buyers to cause such a squeeze. I don't think shorts would cover unless their shares got called in. They'd know that any quick influx in price would likely be the worst time to cover, as the price would probably come down just a bit from those taking profits. Especially with a stock like this that seems to have an incredible amount of traders instead of investors. I guess it's silly to discuss it... You said it best- we'll find out soon enough. I don't know how the hedgies going to play it but I believe there is a lot of shorting in weak hands, guys who believed that GS will take good care.
|
|
|
Post by patten1962 on Apr 3, 2016 18:53:07 GMT -5
Question, to have this short squeeze, what would it take to start it? RLS identity? Overseas partner? Thoughts?
|
|